KFDA instantly to disclose bio equivalency test fraud.

Published: 2006-04-27 06:58:00

Updated: 2006-04-27 06:58:00

Director Moon Byeong-woo, the Drug Safety Division head of KFDA is going to disclose instantly the interim investigations on the manipulated bio equivalency tests at the KFDA briefing room at 10 a.m. on April 25.

In the meeting the manipulated bio equivalency tests will be disclosed and the KF...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK